相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells
Kunio Kosaka et al.
JOURNAL OF BIOCHEMISTRY (2010)
Structure-Activity Relationship and Mechanism of Action Studies of Manzamine Analogues for the Control of Neuroinflammation and Cerebral Infections
Jiangnan Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
6-Hydroxycleroda-3,13-dien-15,16-olide Protects Neuronal Cells from Lipopolysaccharide-Induced Neurotoxicity through the Inhibition of Microglia-Mediated Inflammation
Yu-Tzu Shih et al.
PLANTA MEDICA (2010)
Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases
Xiao-xia Dong et al.
ACTA PHARMACOLOGICA SINICA (2009)
Minocycline and neurodegenerative diseases
Hye-Sun Kim et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1β by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells
Y. Choi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies
S. Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2009)
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ?
Teresa Iuvone et al.
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments
Emmanuel Roze et al.
CURRENT OPINION IN NEUROLOGY (2009)
Small molecule drug discovery for Huntington's Disease
Wolfgang Fecke et al.
DRUG DISCOVERY TODAY (2009)
Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
Orly Weinreb et al.
GENES AND NUTRITION (2009)
Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival
Makoto Naoi et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Stem Cell-Based Cell Therapy in Neurological Diseases: A Review
Seung U. Kim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs
Edmund I. Graziani
NATURAL PRODUCT REPORTS (2009)
Transcriptional regulation of iNOS and COX-2 by a novel compound from Curcuma comosa in lipopolysaccharide-induced microglial activation
Anusorn Thampithak et al.
NEUROSCIENCE LETTERS (2009)
Nanolobatolide, a New C18 Metabolite from the Formosan Soft Coral Sinularia nanolobata
Yen-Ju Tseng et al.
ORGANIC LETTERS (2009)
Plants with neurobiological activity as potential targets for drug discovery
Nelson G. M. Gomes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Mechanisms of Prion Protein Aggregation
Sarah N. Fontaine et al.
PROTEIN AND PEPTIDE LETTERS (2009)
Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease
Jose R. Pineda et al.
MOLECULAR BRAIN (2009)
Functional Models of Parkinson's Disease: A Valuable Tool in the Development of Novel Therapies
Peter Jenner
ANNALS OF NEUROLOGY (2008)
Huntington's disease: from pathology and genetics to potential therapies
Sara Imarisio et al.
BIOCHEMICAL JOURNAL (2008)
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
Preetha Anand et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Small molecule activators of the Trk receptors for neuroprotection
Nicholas J. G. Webster et al.
BMC NEUROSCIENCE (2008)
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis
John Hines et al.
CHEMISTRY & BIOLOGY (2008)
Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases
Hector I. Rocha-Gonzalez et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: An update
Monica Rosa Loizzo et al.
CURRENT MEDICINAL CHEMISTRY (2008)
In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives:: Implications for Parkinson's Disease
J. Andres Abin-Carriquiry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease
Judit Pallos et al.
HUMAN MOLECULAR GENETICS (2008)
Natural products as leads to potential drugs: An old process or the new hope for drug discovery?
David J. Newman
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Alkaloids from the leaves of Uncaria rhynchophylla and their inhibitory activity on NO production in lipopolysaccharide-activated microglia
Dan Yuan et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Neuroprotective limonoids of root bark of Dictamnus dasycarpus
Jeong Seon Yoon et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Xanthones from Gentianella amarella ssp acuta with acetylcholinesterase and monoamine oxidase inhibitory activities
A. Urbain et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Antiparasitic, antineuroinflammatory, and cytotoxic polyketides from the marine sponge Plakortis angulospiculatus collected in Brazil
Miriam H. Kossuga et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Research in motion: the enigma of Parkinson's disease pathology spread
Patrik Brundin et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Role of Nitric Oxide Synthases in Parkinson's Disease: A Review on the Antioxidant and Anti-inflammatory Activity of Polyphenols
Katia Aquilano et al.
NEUROCHEMICAL RESEARCH (2008)
FKBP Family Proteins: Immunophilins with Versatile Biological Functions
Cong Bao Kang et al.
NEUROSIGNALS (2008)
Disease-modifying drugs and Parkinson's disease
Herve Allain et al.
PROGRESS IN NEUROBIOLOGY (2008)
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
Sovan Sarkar et al.
HUMAN MOLECULAR GENETICS (2008)
The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias
Janet E. Davies et al.
BMC BIOCHEMISTRY (2007)
Bioactivity profiling with parallel mass Spectrometry reveals an assemblage of green tea metabolites affording protection against human huntingtin and α-synuclein toxicity
Russell B. Williams et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line
Da-Long Zhao et al.
NEUROPHARMACOLOGY (2007)
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
Amanda L. Sheldon et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Neurodegeneration in models of Gram-positive bacterial infections of the central nervous system
J. J. Neher et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Neuroprotective effects of natural products: Interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin
Stephane Bastianetto et al.
NEUROCHEMICAL RESEARCH (2007)
Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity
Sevda Dirikoc et al.
JOURNAL OF NEUROSCIENCE (2007)
Acetylcholinesterase inhibition by flavonoids from agrimonia pilosa
Mankil Jung et al.
MOLECULES (2007)
Advances in small molecules promoting neurotrophic function
Raymond D. Price et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Panaxadiol glycosides that induce neuronal differentiation in neurosphere stem cells
Jia Wei Liu et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Understanding the natural variability of prion diseases
Markus Geissen et al.
VACCINE (2007)
Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease
Da-Zhi Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Inflammatory caspases: Targets for novel therapies
Sigrid Cornelis et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Natural products as sources of new drugs over the last 25 years
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease
Mark Hamann et al.
JOURNAL OF NATURAL PRODUCTS (2007)
The 6-hydroxydopamine model of Parkinson's disease
Nicola Simola et al.
NEUROTOXICITY RESEARCH (2007)
An update on pharmacological approaches to neurodegenerative diseases
Roberto Scatena et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Microglial activation and its implications in the brain diseases
S. Thameem Dheen et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Thapsigargin-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells
Tsuneo Takadera et al.
NEUROSCIENCE LETTERS (2006)
Drug insight: new drugs in development for Parkinson's disease
Carlo Colosimo et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III
Asun Solans et al.
HUMAN MOLECULAR GENETICS (2006)
Novel pharmacological targets for the treatment of Parkinson's disease
Anthony H. V. Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease
Lindsay R. Pattison et al.
JOURNAL OF NEUROLOGY (2006)
Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases
Cornelis J. Van der Schyf et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation
David Hernandez-Espinosa et al.
BRAIN RESEARCH BULLETIN (2006)
Neuroprotective bibenzyl glycosides of Stemona tuberosa roots
KY Lee et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
CG Glabe
NEUROBIOLOGY OF AGING (2006)
(+)-N-deoxymillitarinone A, a neuritogenic pyridone alkaloid from the insect pathogenic fungus Paecilomyces farinosus
YX Cheng et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Rapamycin alleviates toxicity of different aggregate-prone proteins
Z Berger et al.
HUMAN MOLECULAR GENETICS (2006)
Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee
T Herraiz et al.
LIFE SCIENCES (2006)
Molecular and biochemical features in Alzheimer's disease
Merce Pallas et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Pharmacological intervention at ionotropic glutamate receptor complexes
Rosa Planells-Cases et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Anti-inflammatory drugs in the treatment of neurodegenerative diseases: Current state
Yossi Gilgun-Sherki et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
A new neuroprotective compound of Ligustrum japonicum leaves
SH Sung et al.
PLANTA MEDICA (2006)
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets
Charles Ramassamy
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
15,16-Dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide
P Lee et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Total synthesis as a resource in drug discovery: The first in vivo evaluation of panaxytriol and its derivatives
HD Yun et al.
JOURNAL OF ORGANIC CHEMISTRY (2005)
New anti-Alzheimer drugs from biodiversity: The role of the natural acetylcholinesterase inhibitors
C Viegas et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Minocycline as a neuroprotective agent
DP Stirling et al.
NEUROSCIENTIST (2005)
Amphotericin B
A Lemke et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
JA Parker et al.
NATURE GENETICS (2005)
Search for natural products related to regeneration of the neuronal network
C Tohda et al.
NEUROSIGNALS (2005)
Multifunctional activities of green tea catechins in neuroprotection - Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway
SA Mandel et al.
NEUROSIGNALS (2005)
Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease
PJ Houghton et al.
NEUROSIGNALS (2005)
Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation
J Wang et al.
BMC NEUROSCIENCE (2005)
Four new neuroprotective dihydropyranocoumarins from Angelica gigas
SY Kang et al.
JOURNAL OF NATURAL PRODUCTS (2005)
Natural products as a source of CNS-active agents
JA Clement et al.
MINI-REVIEWS IN ORGANIC CHEMISTRY (2004)
(-)-3,5-dicaffeoyl-muco-quinic acid isolated from Aster scaber contributes to the differentiation of PC12 cells:: through tyrosine kinase cascade signaling
JY Hur et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Activity of macrocyclic jatrophane diterpenes from Euphorbia kansui in a TrkA fibroblast survival assay
Q Pan et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Catechin polyphenols: Neurodegeneration and neuroprotection in neurodegenerative diseases
S Mandel et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Clinical potential of minocycline for neurodegenerative disorders
D Blum et al.
NEUROBIOLOGY OF DISEASE (2004)
The role of natural product chemistry in drug discovery
MS Butler
JOURNAL OF NATURAL PRODUCTS (2004)
Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
RJ Ferrante et al.
JOURNAL OF NEUROSCIENCE (2004)
Farinosones A-C, neurotrophic alkaloidal metabolites from the entomogenous deuteromycete Paecilomyces farinosus
YX Cheng et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Galanthamine from snowdrop - the development of a modern drug against Alzheimer's disease from local Caucasian knowledge
M Heinrich et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
New inhibitors of scrapie-associated prion protein formation in a library of 2,000 drugs and natural products
DA Kocisko et al.
JOURNAL OF VIROLOGY (2003)
Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism
MJ Schwarz et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)
Inhibition of protease-resistant prion protein accumulation in vitro by curcumin
B Caughey et al.
JOURNAL OF VIROLOGY (2003)
1-methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase
MK Lee et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2003)
Sphingolipids from Bombycis corpus 101A and their neurotrophic effects
HC Kwon et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Novel tetramic acids and pyridone alkaloids, militarinones B, C, and D, from the insect pathogenic fungus Paecilomyces militaris
K Schmidt et al.
JOURNAL OF NATURAL PRODUCTS (2003)
Neuroimmunophilin ligands: The development of novel neuroregenerative/neuroprotective compounds
BG Gold et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2003)
Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells
C Tohda et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis Rhizoma extract and protoberberine alkaloids
K Shigeta et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2002)
Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots
SR Kim et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha
T Kuboyama et al.
NEUROREPORT (2002)
Glycogen synthase kinase-3β inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation
J Carmichael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons
Y Fukuyama et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
New seco-prezizaane-type sesquiterpenes, jiadifenin with neurotrophic activity and 1,2-dehydroneomajucin from Illicium jiadifengpi
R Yokoyama et al.
JOURNAL OF NATURAL PRODUCTS (2002)
Militarinone A, a neurotrophic pyridone alkaloid from Paecilomyces militaris
K Schmidt et al.
ORGANIC LETTERS (2002)
Inhibition of type A monoamine oxidase by coptisine in mouse brain
JS Ro et al.
LIFE SCIENCES (2001)
Structure-activity relationship of a neurite outgrowth-promoting substance purified from the brown alga, Sargassum macrocarpum, and its analogues on PC12D cells
CK Tsang et al.
JOURNAL OF APPLIED PHYCOLOGY (2001)
Potentiation of nerve growth factor-induced elongation of neurites by gelsemiol and 9-hydroxysemperoside aglucone in PC12D cells
YS Li et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Inhibitory effect of fangchinoline on excitatory amino acids-induced neurotoxicity in cultured rat cerebellar granule cells
SD Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2001)
Structure and neurotrophic activity of seco-prezizaane-type sesquiterpenes from Illicium merrillianum
JM Huang et al.
JOURNAL OF NATURAL PRODUCTS (2001)
New manzamine alkaloids with potent activity against infectious diseases
KA El Sayed et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Potentiation of nerve growth factor-action by picrosides I and II, natural iridoids, in PC12D cells
P Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Merrilactone A, a novel neurotrophic sesquiterpene dilactone from Illicium merrillianum
JM Huang et al.
TETRAHEDRON LETTERS (2000)
Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis -: Protection by lithium
GN Bijur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures
A Mangé et al.
JOURNAL OF VIROLOGY (2000)
Inhibition of cyclin-dependent kinases, GSK-3 beta and CK1 by hymenialdisine, a marine sponge constituent
L Meijer et al.
CHEMISTRY & BIOLOGY (2000)
分享论文
